IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2015 Holdings

Filed 2016-02-16 | 17 holdings | $190.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$95.0M310,00049.9%
Abbvie Inc.(ABBV)COM00287Y109$93.6M1,580,00049.2%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$1.4M31,0000.7%
Ariad Pharmaceuticals IncCOM04033A100$80.3K12,850,0000.0%
Medicines CoCOM584688105$58.5K1,567,0000.0%
Quest Diagnostics Inc(DGX)COM74834L100$40.9K575,0000.0%
Pacira Pharmaceuticals Inc(PCRX)COM695127100$40.9K532,2000.0%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$36.3K675,0000.0%
Aegerion Pharmaceuticals IncCOM00767E102$26.1K2,580,0000.0%
Amgen Inc(AMGN)COM031162100$14.6K90,0000.0%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$10.0K448,0000.0%
Apricus Biosciences IncCOM03832V109$6.5K6,524,5050.0%
Array Biopharma Inc(ARRYEUR)COM04269X105$3.0K700,0000.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$2.9K2,313,7590.0%
Vivus IncCOM928551100$2.6K2,573,9430.0%
Repros Therapeutics IncCOM NEW76028H209$1.2K1,001,0000.0%
Targacept IncNOTE 2/187611RAA6$680$680,3990.0%